Promising Lilly cancer drug fails in disappointing trial, shares fall 3 percent
Analysts had predicted that Lartruvo could eventually ring up as much as $600 million in annual sales. Eli Lilly and Co. now says it will suspend promotion of the drug.
Analysts had predicted that Lartruvo could eventually ring up as much as $600 million in annual sales. Eli Lilly and Co. now says it will suspend promotion of the drug.
The Catalyst Award recognizes companies that excel in addressing recruitment, development and advancement of women. Today, nearly half of Lilly's senior leadership is female, up from 20 percent four years ago.
The Indianapolis-based provider of health clinics for businesses has grown to 250 employees in 10 years. But it recently started looking for another owner.
The Indianapolis company, formed in 2009, makes apps that allow users to track buses in real time and hail rides on demand. It is merging with Ride Systems LLC to gain more users and build market share.
Two bills going through the Indiana General Assembly would give the state more tools to scrutinize the powerful pharmacy-benefits managers who negotiate drug prices and help set customer prices.
State Sen. John Ruckelshaus said too many new hospitals, especially in small wealthy clusters, might be driving up the cost of health care. He said his bill was prompted by a recent effort by St. Vincent to rezone a 30-acre site in Carmel.
The projects range from full-service hospitals in Bloomington, Brownsburg and Shelbyville to a flurry of “micro-hospitals,” free-standing emergency rooms and urgent care centers.
Starting Jan. 1, every U.S. hospital will be required to post standard charges online for every item and service they provide, from bandages and drugs to operating rooms and organ transplants.
Gosling has sold about 700,000 sticks since creating the product in his kitchen in 2004.
Rogers’ path to building the nation’s largest electric utility began in 1988, when he took over struggling PSI Energy in Indiana.
The Indianapolis drugmaker said its 2-year-old anti-inflammatory medicine showed superiority in a head-to-head trial against Humira, the world’s best-selling drug, for treating psoriatic arthritis.
The penalties will be as much as 2 percent of Medicare reimbursements, and could be worth millions of dollars to large nursing-home chains with locations spread across Indiana and the nation.
The health system said the 15-year-old elevated train service needs major maintenance, but did not say whether the system would ever return to service.
David Johnson, who has led the life science advocacy and investment group for 14 years, will take over full-time leadership of the Central Indiana Corporate Partnership in 2019.
Entrepreneur Michael Arnolt teamed with an inventor more than 20 years ago to launch an enterprise that has sold thousands of steel therapy instruments and trained thousands of clinicians.
The company is planning to add up to 1,330 jobs over the next eight years, focused mainly on its Regentec division in Indianapolis and its Profile Park in Bloomington, site of a former GE refrigerator factory.
Solinftec said Thursday it would invest $50.6 million to establish operations in the Hoosier state. The company makes technology that helps farmers collect and analyze data to increase crop returns.
At issue in the five-year legal dispute was whether Dr. Rick Sasso was properly compensated for various inventions, and whether Minnesota-based Medtronic paid him sufficient royalties as spelled out in their agreements.
It’s the foundation’s first capital campaign since 2010, when it raised $200 million. The money will be used for pediatric research, patient care, maternity and newborn health, and family support programs.
Dr. John Williams, dean since 2010, is stepping down next summer after turning 67, in accordance with university policy. He helped raise more than $70 million and expanded the school’s clinical space by about one-third.